PENUMBRA INC (PEN) Stock Fundamental Analysis
USA - NYSE:PEN - US70975L1070 - Common Stock
280.07 USD
+1.33 (+0.48%)
280.07 USD
0 (0%)
PEN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. PEN has an excellent financial health rating, but there are some minor concerns on its profitability. PEN is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make PEN suitable for growth investing!
1. Profitability
1.1 Basic Checks
PEN had positive earnings in the past year.
In the past year PEN had a positive cash flow from operations.
In multiple years PEN reported negative net income over the last 5 years.
In multiple years PEN reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 9.40%, PEN belongs to the top of the industry, outperforming 91.49% of the companies in the same industry.
With an excellent Return On Equity value of 12.07%, PEN belongs to the best of the industry, outperforming 87.77% of the companies in the same industry.
PEN has a Return On Invested Capital of 7.37%. This is amongst the best in the industry. PEN outperforms 81.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PEN is significantly below the industry average of 8.98%.
The 3 year average ROIC (2.98%) for PEN is below the current ROIC(7.37%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.4% | ||
| ROE | 12.07% | ||
| ROIC | 7.37% |
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
1.3 Margins
PEN has a Profit Margin of 12.30%. This is amongst the best in the industry. PEN outperforms 87.77% of its industry peers.
PEN's Profit Margin has declined in the last couple of years.
PEN has a better Operating Margin (12.95%) than 79.79% of its industry peers.
In the last couple of years the Operating Margin of PEN has declined.
With a decent Gross Margin value of 66.80%, PEN is doing good in the industry, outperforming 71.28% of the companies in the same industry.
In the last couple of years the Gross Margin of PEN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.95% | ||
| PM (TTM) | 12.3% | ||
| GM | 66.8% |
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PEN is destroying value.
Compared to 1 year ago, PEN has less shares outstanding
Compared to 5 years ago, PEN has more shares outstanding
The debt/assets ratio for PEN has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 18.91 indicates that PEN is not in any danger for bankruptcy at the moment.
The Altman-Z score of PEN (18.91) is better than 95.21% of its industry peers.
PEN has a debt to FCF ratio of 0.15. This is a very positive value and a sign of high solvency as it would only need 0.15 years to pay back of all of its debts.
PEN has a better Debt to FCF ratio (0.15) than 93.62% of its industry peers.
PEN has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
PEN has a Debt to Equity ratio of 0.02. This is in the better half of the industry: PEN outperforms 70.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.15 | ||
| Altman-Z | 18.91 |
ROIC/WACC0.84
WACC8.77%
2.3 Liquidity
PEN has a Current Ratio of 6.73. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.73, PEN belongs to the best of the industry, outperforming 84.57% of the companies in the same industry.
A Quick Ratio of 4.18 indicates that PEN has no problem at all paying its short term obligations.
PEN's Quick ratio of 4.18 is fine compared to the rest of the industry. PEN outperforms 78.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.73 | ||
| Quick Ratio | 4.18 |
3. Growth
3.1 Past
PEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.47%, which is quite impressive.
Measured over the past years, PEN shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.23% on average per year.
PEN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.61%.
PEN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.89% yearly.
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%
3.2 Future
The Earnings Per Share is expected to grow by 25.57% on average over the next years. This is a very strong growth
Based on estimates for the next years, PEN will show a quite strong growth in Revenue. The Revenue will grow by 13.32% on average per year.
EPS Next Y31.54%
EPS Next 2Y33.19%
EPS Next 3Y30.6%
EPS Next 5Y25.57%
Revenue Next Year14.71%
Revenue Next 2Y14.46%
Revenue Next 3Y14.21%
Revenue Next 5Y13.32%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 77.15, which means the current valuation is very expensive for PEN.
Based on the Price/Earnings ratio, PEN is valued a bit cheaper than the industry average as 65.96% of the companies are valued more expensively.
PEN is valuated expensively when we compare the Price/Earnings ratio to 25.89, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 55.01, which means the current valuation is very expensive for PEN.
Based on the Price/Forward Earnings ratio, PEN is valued a bit cheaper than the industry average as 68.09% of the companies are valued more expensively.
PEN is valuated expensively when we compare the Price/Forward Earnings ratio to 34.59, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 77.15 | ||
| Fwd PE | 55.01 |
4.2 Price Multiples
65.96% of the companies in the same industry are more expensive than PEN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, PEN is valued a bit cheaper than 70.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 71.57 | ||
| EV/EBITDA | 54.3 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PEN does not grow enough to justify the current Price/Earnings ratio.
PEN has a very decent profitability rating, which may justify a higher PE ratio.
PEN's earnings are expected to grow with 30.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.45
PEG (5Y)3.18
EPS Next 2Y33.19%
EPS Next 3Y30.6%
5. Dividend
5.1 Amount
No dividends for PEN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
280.07
+1.33 (+0.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners93.23%
Inst Owner Change6.27%
Ins Owners3.71%
Ins Owner Change23.09%
Market Cap10.92B
Revenue(TTM)1.33B
Net Income(TTM)164.03M
Analysts83.33
Price Target320.45 (14.42%)
Short Float %4.62%
Short Ratio4.28
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.92%
Min EPS beat(2)3.63%
Max EPS beat(2)4.22%
EPS beat(4)4
Avg EPS beat(4)9.67%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)11.2%
EPS beat(12)12
Avg EPS beat(12)25.5%
EPS beat(16)14
Avg EPS beat(16)17.71%
Revenue beat(2)2
Avg Revenue beat(2)2.8%
Min Revenue beat(2)2.56%
Max Revenue beat(2)3.05%
Revenue beat(4)4
Avg Revenue beat(4)1.89%
Min Revenue beat(4)0.28%
Max Revenue beat(4)3.05%
Revenue beat(8)6
Avg Revenue beat(8)0.73%
Revenue beat(12)10
Avg Revenue beat(12)1.17%
Revenue beat(16)12
Avg Revenue beat(16)1.31%
PT rev (1m)0.5%
PT rev (3m)0.25%
EPS NQ rev (1m)-0.45%
EPS NQ rev (3m)0.06%
EPS NY rev (1m)0.26%
EPS NY rev (3m)-0.74%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 77.15 | ||
| Fwd PE | 55.01 | ||
| P/S | 8.19 | ||
| P/FCF | 71.57 | ||
| P/OCF | 53.73 | ||
| P/B | 8.04 | ||
| P/tB | 9.21 | ||
| EV/EBITDA | 54.3 |
EPS(TTM)3.63
EY1.3%
EPS(NY)5.09
Fwd EY1.82%
FCF(TTM)3.91
FCFY1.4%
OCF(TTM)5.21
OCFY1.86%
SpS34.2
BVpS34.84
TBVpS30.4
PEG (NY)2.45
PEG (5Y)3.18
Graham Number53.34
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.4% | ||
| ROE | 12.07% | ||
| ROCE | 10.97% | ||
| ROIC | 7.37% | ||
| ROICexc | 10.5% | ||
| ROICexgc | 12.46% | ||
| OM | 12.95% | ||
| PM (TTM) | 12.3% | ||
| GM | 66.8% | ||
| FCFM | 11.44% |
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.84%
ROICexc(5y)N/A
ROICexgc(3y)4.75%
ROICexgc(5y)N/A
ROCE(3y)4.43%
ROCE(5y)N/A
ROICexgc growth 3Y49.31%
ROICexgc growth 5Y-5.8%
ROICexc growth 3Y58%
ROICexc growth 5Y-7.52%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
F-Score7
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.15 | ||
| Debt/EBITDA | 0.11 | ||
| Cap/Depr | 291.22% | ||
| Cap/Sales | 3.8% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 106.89% | ||
| Profit Quality | 93.05% | ||
| Current Ratio | 6.73 | ||
| Quick Ratio | 4.18 | ||
| Altman-Z | 18.91 |
F-Score7
WACC8.77%
ROIC/WACC0.84
Cap/Depr(3y)74.85%
Cap/Depr(5y)109.14%
Cap/Sales(3y)1.83%
Cap/Sales(5y)2.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
EPS Next Y31.54%
EPS Next 2Y33.19%
EPS Next 3Y30.6%
EPS Next 5Y25.57%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%
Revenue Next Year14.71%
Revenue Next 2Y14.46%
Revenue Next 3Y14.21%
Revenue Next 5Y13.32%
EBIT growth 1Y54.5%
EBIT growth 3Y67.65%
EBIT growth 5Y12.66%
EBIT Next Year74.3%
EBIT Next 3Y39.57%
EBIT Next 5Y28.16%
FCF growth 1Y222.8%
FCF growth 3YN/A
FCF growth 5Y100.55%
OCF growth 1Y225.73%
OCF growth 3Y160.78%
OCF growth 5Y44.6%
PENUMBRA INC / PEN FAQ
What is the ChartMill fundamental rating of PENUMBRA INC (PEN) stock?
ChartMill assigns a fundamental rating of 6 / 10 to PEN.
Can you provide the valuation status for PENUMBRA INC?
ChartMill assigns a valuation rating of 4 / 10 to PENUMBRA INC (PEN). This can be considered as Fairly Valued.
What is the profitability of PEN stock?
PENUMBRA INC (PEN) has a profitability rating of 6 / 10.
What are the PE and PB ratios of PENUMBRA INC (PEN) stock?
The Price/Earnings (PE) ratio for PENUMBRA INC (PEN) is 77.15 and the Price/Book (PB) ratio is 8.04.
Can you provide the financial health for PEN stock?
The financial health rating of PENUMBRA INC (PEN) is 8 / 10.